2014
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities
Heimer R, Eritsyan K, Barbour R, Levina OS. Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities. BMC Infectious Diseases 2014, 14: s12. PMID: 25253447, PMCID: PMC4178532, DOI: 10.1186/1471-2334-14-s6-s12.Peer-Reviewed Original ResearchConceptsHepatitis C virusRespondent-driven samplingHIV-1Hepatitis C virus (HCV) seroprevalencePositive HCV serostatusInjection drug useLarger social network sizeHarm reduction programsHCV-positive serostatusBetter prevention programsHCV prevalenceHCV serostatusHCV epidemicMean ageC virusInjection paraphernaliaVirus seroprevalenceSerological testingRisk populationsBlood specimensCity-level factorsPWIDDrug usePrevention programsLonger duration
2009
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection
Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction 2009, 104: 1881-1890. PMID: 19712125, PMCID: PMC2763027, DOI: 10.1111/j.1360-0443.2009.02687.x.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis C virusRespondent-driven samplingPrevalent infectionMajority of IDUsHepatitis C virus infectionSustained virological responseC virus infectionRespondent-driven sampleAssociation of genotypesIDU communityVirological responseHCV infectionAntiviral therapyC virusGenotype 3aDrug injectionVirus infectionDrug injectorsBlood samplesHCV sequencesDrug usersEndemic infectionInfectionMolecular epidemiology